Michael R Downing

Title: Innovator Spotlight: Michael R. Downing and His Solutions for Iron Overload

Introduction: Michael R. Downing, based in Thousand Oaks, CA, is an accomplished inventor with significant contributions to the medical field. His innovative approach addresses the critical issue of iron overload in mammals, specifically through the use of erythropoietin (EPO).

Latest Patents: Downing holds a patent titled "Method for treating iron overload using EPO". This patent outlines a method for reducing stored iron and serum iron levels in mammals with iron overload disorders. By administering a therapeutically effective amount of erythropoietin, the production of red blood cells is increased, followed by a phlebotomy procedure to remove the excess red blood cells produced.

Career Highlights: Throughout his career, Michael has worked with Amgen Inc., a leading biotechnology company renowned for its commitment to innovative therapies. His work at Amgen has placed him in the forefront of biomedical research, contributing valuable insights into iron metabolism.

Collaborations: At Amgen, Downing collaborates with distinguished colleagues such as John W. Adamson and Joseph W. Eschbach. Together, they explore novel treatments and methodologies that advance the understanding and treatment of various medical conditions.

Conclusion: Michael R. Downing's pioneering work in addressing iron overload through innovative methods exemplifies the impact of inventors in the field of medicine. His patent not only showcases his creativity but also highlights the importance of collaboration among scientists and researchers in driving advancements in therapeutic solutions.